Browse all articles

Home Get the app
Fucoxanthin

Fucoxanthin

Evidence status

Limited evidence to recommend for any consumer outcome yet.

3 papers · 1 claim · 27 outcomes scored

Outcomes

What fucoxanthin actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect Evidence Dose Weeks Rank
Boost your resting metabolic rate Not enough research
1 RCT n=— 2 mg 8 wk —

Risk profile

Adverse events and known drug interactions

Safety events

Phototoxicity (concern based on chlorophyll degradation products PHA/PPHA) moderate
palpitations mild
blurred vision mild
dizziness mild
palpitations (minimal severity) mild
headache mild
tachycardia mild
heart palpitations mild

Drug interactions

Rifampin moderate decreases effect
Cisplatin moderate increases toxicity

Co-studied with

Supplements that share evidence with fucoxanthin

Sources

  1. 1. Effects of Supplementation with Microalgae Extract from Phaeodactylum tricornutum (Mi136) to Support Benefits from a Weight Management Intervention in Overweight Women. (2024) ↑
  2. 2. Reduction of HbA1c levels by fucoxanthin-enriched akamoku oil possibly involves the thrifty allele of uncoupling protein 1 (UCP1): a randomised controlled trial in normal-weight and obese Japanese adults. (2017) ↑
  3. 3. Effects of Supplementation with a Microalgae Extract from Phaeodactylum tricornutum Containing Fucoxanthin on Cognition and Markers of Health in Older Individuals with Perceptions of Cognitive Decline. (2024) ↑

Generated August 14, 2026

Related

More evidence for Fucoxanthin

Want personalized recommendations?

Show me what works for me